Core Labs Q2 revenue beats estimates

Core Laboratories

23/07/2025 22:30

Overview

Core Labs Q2 revenue of $130.2 mln beats analyst expectations, per LSEG data

Adjusted EPS for Q2 rises 33% sequentially, down 14% yr/yr

Co repurchased 237,632 shares valued at $2.7 mln, reduced net debt by $9.1 mln

Outlook

Core Labs projects Q3 revenue between $127.5 mln and $134.5 mln

Oilfield reservoir management services provider expects Q3 EPS to be $0.18 to $0.22

Core anticipates sequentially flat Q3 revenue for Reservoir Descriptions

Geopolitical issues and softer U.S. land activity present near-term challenges, according to co

Company sees soft U.S. market offset by international service growth

Result Drivers

INTERNATIONAL DEMAND - Sequential revenue growth driven by strengthened demand for services and products across international network

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
Beat
$130.20 mln
$128.80 mln (4 Analysts)
Q2 EPS
$0.22


Analyst Coverage

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 3 "hold" and 1 "sell" or "strong sell"

The average consensus recommendation for the business support services peer group is "buy."

Wall Street's median 12-month price target for Core Laboratories Inc is $13.00, about 2.9% above its July 23 closing price of $12.62

The stock recently traded at 15 times the next 12-month earnings vs. a P/E of 17 three months ago

Press Release: ID:nPn1fgxzra

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)